Stevanato Group S.p.A. (STVN:NYSE) closed at $19.31 on October 14, 2026, up 0.26% on the day. The stock trades 31.0% below its 52-week high of $27.99 and 49.8% above its 52-week low of $12.89. Over the past year, it lost 20.1%. Stevanato Group S.p.A. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -0.72% | -9.66% | -4.18% | +24.02% | -20.15% |
In 252 trading sessions since October 14, 2025, STVN closed higher on 120 days (48%). Its best day was March 4, 2026 (+18.81%) and its worst was January 23, 2026 (-9.86%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 2 times.
Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.
Find more stocks like STVN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.